CEO Michael Hurlston went on live television and said something you almost never hear from a public company executive: “We’re sold out really until the end of 2027. We see no end in sight.” That’s not ...
Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – eligible for PEA PME), a next-generation biopharmaceutical company developing innovative therapies in sepsis and critical care based on an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results